New York · 2025 Regular Session · Bill
S 9279: Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 9279 is a bill introduced in the New York Senate on February 24, 2026. According to its official title, it concerns: Relates to the operation of gene synthesis providers and manufacturers of gene synthesis equipment. Primary sponsor: Michael Gianaris. Most recent recorded action (June 2, 2026): SUBSTITUTED BY A3283C.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Michael Gianaris | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- SUBSTITUTED BY A3283C
- ADVANCED TO THIRD READING
- 2ND REPORT CAL.
- 1ST REPORT CAL.1239
- PRINT NUMBER 9279A
- AMEND AND RECOMMIT TO HEALTH
- REFERRED TO HEALTH